832: Optimized Intravesical Mitomycin C Treatment for Superficial Bladder Cancer: Long-Term Follow-Up

Jessie L. Au; Robert A. Badalament; M. Guillaume Wientjes; Donn C. Young; Tong Shen; Pieter L. Venema; David L. Pollifrone; Jeffrey D. Harbrecht; Joseph L. Chin; Seth P. Lerner; Brian J. Miles

doi:10.1016/S0022-5347(18)33068-4

832: Optimized Intravesical Mitomycin C Treatment for Superficial Bladder Cancer: Long-Term Follow-Up

Jessie L. Au
, Robert A. Badalament
, M. Guillaume Wientjes
, Donn C. Young
, Tong Shen
, Pieter L. Venema
, David L. Pollifrone
, Jeffrey D. Harbrecht
, Joseph L. Chin
, Seth P. Lerner
, Brian J. Miles

HCA Healthcare

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	The Journal of Urology
Volume	175
DOIs	https://doi.org/10.1016/S0022-5347(18)33068-4
State	Published - Apr 1 2006

Disciplines

Medicine and Health Sciences
Urology

Access to Document

10.1016/S0022-5347(18)33068-4License: Unspecified

Cite this

@article{01f723f0119c4bf4856217a2a17ebde2,

title = "832: Optimized Intravesical Mitomycin C Treatment for Superficial Bladder Cancer: Long-Term Follow-Up",

author = "Au, \{Jessie L.\} and Badalament, \{Robert A.\} and Wientjes, \{M. Guillaume\} and Young, \{Donn C.\} and Tong Shen and Venema, \{Pieter L.\} and Pollifrone, \{David L.\} and Harbrecht, \{Jeffrey D.\} and Chin, \{Joseph L.\} and Lerner, \{Seth P.\} and Miles, \{Brian J.\}",

note = "DISCLOSURES: The American Urological Association (AUA) is committed to maintaining transparency in its relationships. The AUA requires that individuals make full disclosures for themselves, their family and/or business partner of relationships, business transactions, leadership positions, presentations or publications prior to participating in AUA activities. All relevant relationships for the last 12 months should be disclosed.",

year = "2006",

month = apr,

day = "1",

doi = "10.1016/S0022-5347(18)33068-4",

language = "American English",

volume = "175",

journal = "The Journal of Urology",

}

TY - JOUR

T1 - 832: Optimized Intravesical Mitomycin C Treatment for Superficial Bladder Cancer: Long-Term Follow-Up

AU - Au, Jessie L.

AU - Badalament, Robert A.

AU - Wientjes, M. Guillaume

AU - Young, Donn C.

AU - Shen, Tong

AU - Venema, Pieter L.

AU - Pollifrone, David L.

AU - Harbrecht, Jeffrey D.

AU - Chin, Joseph L.

AU - Lerner, Seth P.

AU - Miles, Brian J.

N1 - DISCLOSURES: The American Urological Association (AUA) is committed to maintaining transparency in its relationships. The AUA requires that individuals make full disclosures for themselves, their family and/or business partner of relationships, business transactions, leadership positions, presentations or publications prior to participating in AUA activities. All relevant relationships for the last 12 months should be disclosed.

PY - 2006/4/1

Y1 - 2006/4/1

UR - https://www.auajournals.org/doi/10.1016/S0022-5347%2818%2933068-4

U2 - 10.1016/S0022-5347(18)33068-4

DO - 10.1016/S0022-5347(18)33068-4

M3 - Article

VL - 175

JO - The Journal of Urology

JF - The Journal of Urology

ER -

832: Optimized Intravesical Mitomycin C Treatment for Superficial Bladder Cancer: Long-Term Follow-Up

Disciplines

Access to Document

Other files and links

Cite this